Association of HER2DX with pathological complete response and survival outcomes in HER2-positive breast cancer. Villacampa G, Tung NM, Pernas S, Pare L, et al. Ann Oncol 2023 Jun 9:S0923-7534(23)00721-4. doi: 10.1016/j.annonc.2023.

Read + Share

Amedeo Smart

Independent Medical Education

Villacampa G, Tung NM, Pernas S, Pare L, et al. Association of HER2DX with pathological complete response and survival outcomes in HER2-positive breast cancer. Ann Oncol 2023 Jun 9:S0923-7534(23)00721-4. doi: 10.1016/j.annonc.2023.
PMID: 37302750